Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress Vishay Intertechnology VSH Q1 2026 Earnings EPS Surprise Drives DoubleDigit Stock Rally RMBI Q1 2026 Earnings Solid EPS Performance Amid Quiet Quarter KW Q1 2026 Earnings Strong EPS Surprise Amidst Challenging Market OXLCN Q4 2025 Earnings EPS Misses Estimates Amid Stable Preferred Distribution CACC Q1 2026 Earnings EPS Slightly Misses Estimates Amid Subprime Auto Lending Environment